← Leaderboards
Bhagavathi A Narayanan
New York University School Of Medicine
$1,830,781
Attributed
$1,830,781
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $396.3K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,830,781 · 2
By mechanism
R01$1,661,781 · 1
R03$169,000 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Maarten C Bosland$10,491,195
- Benjamin G. Neel$33,134,772
- Max Costa$33,497,930
- Michael J Garabedian$7,578,313
Others in their field
Top investigators on “Chemoprevention”
- Charles A Coltman · Southwest Oncology Group$144,723,158
- Norman Wolmark · Nsabp Foundation, Inc.$110,141,959
- John Anthony Baron · Dartmouth College$61,176,184
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
Research focus
ChemopreventionApoptosisNonsteroidal Antiinflammatory AgentDesignCyclic GmpBiologicalAccountingCancer ControlClinical TrialsCarcinogenesisAnti-InflammatoryCaspaseCdna ArraysCelecoxibCessation Of LifeAnti-Inflammatory AgentsChemopreventive AgentClinical Course Of DiseaseAdverse EffectsColonColon CarcinogenesisColon CarcinomaAspirinCyclooxygenase 1
Grant awards (8)
Chemopreventive Effect of NSAIDs Against Prostate Cancer$142,400
R01 · FY2009 · CA · contact PI
Chemopreventive Effect of NSAIDs Against Prostate Cancer$295,647
R01 · FY2008 · CA · contact PI
Chemopreventive Effect of NSAIDs Against Prostate Cancer$295,647
R01 · FY2007 · CA · contact PI
Chemopreventive Effect of NSAIDs Against Prostate Cancer$304,477
R01 · FY2006 · CA · contact PI
Chemopreventive Effect of NSAIDs Against Prostate Cancer$311,805
R01 · FY2005 · CA
Chemoprevention: Non-Cox-2 Targets of Celecoxib in PCa$84,500
R03 · FY2005 · CA
Chemopreventive Effect of NSAIDs Against Prostate Cancer$311,805
R01 · FY2004 · CA
Chemoprevention: Non-Cox-2 Targets of Celecoxib in PCa$84,500
R03 · FY2004 · CA